HLB Life Science Co. Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.016x

HLB Life Science Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, HLB Life Science Co. Ltd (067630) has a cash flow conversion efficiency ratio of -0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.30 Billion ≈ $-2.92 Million USD) by net assets (₩277.26 Billion ≈ $187.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of HLB Life Science Co. Ltd (2012–2024)

Cash flow conversion efficiency of HLB Life Science Co. Ltd from 2012 to 2024. This chart illustrates how HLB Life Science Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View HLB Life Science Co. Ltd share price for real-time trading data and today's change.

HLB Life Science Co. Ltd Cash Flow Conversion Ratio Explained

HLB Life Science Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

HLB Life Science Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HLB Life Science Co. Ltd ranked by their cash flow conversion efficiency. Also see HLB Life Science Co. Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Bogota Financial Corp NASDAQ:BSBK	0.002x
Agung Podomoro Land Tbk JK:APLN	-0.004x
Health Catalyst Inc NASDAQ:HCAT	0.186x
Gossamer Bio Inc NASDAQ:GOSS	0.439x
Adel Kalemcilik Ticaret ve Sanayi AS IS:ADEL	-0.453x
Thuan Duc JSC VN:TDP	0.282x
icad inc NASDAQ:ICAD	0.002x
Kyung Nong Corporation KO:002100	-0.043x

Annual Cash Flow Conversion Efficiency for HLB Life Science Co. Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of HLB Life Science Co. Ltd from 2012 to 2024. Review 067630 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩398.83 Billion ≈ $270.28 Million	₩-32.01 Billion ≈ $-21.69 Million	-0.080x	-85.25%
2023-12-31	₩231.21 Billion ≈ $156.69 Million	₩-10.02 Billion ≈ $-6.79 Million	-0.043x	+65.81%
2022-12-31	₩234.72 Billion ≈ $159.07 Million	₩-29.74 Billion ≈ $-20.16 Million	-0.127x	-121.50%
2021-12-31	₩246.19 Billion ≈ $166.84 Million	₩-14.08 Billion ≈ $-9.54 Million	-0.057x	-917.36%
2020-12-31	₩287.18 Billion ≈ $194.62 Million	₩2.01 Billion ≈ $1.36 Million	0.007x	+118.86%
2019-12-31	₩333.82 Billion ≈ $226.23 Million	₩-12.39 Billion ≈ $-8.39 Million	-0.037x	+26.58%
2018-12-31	₩219.09 Billion ≈ $148.47 Million	₩-11.07 Billion ≈ $-7.50 Million	-0.051x	-783.95%
2017-12-31	₩52.83 Billion ≈ $35.80 Million	₩-302.04 Million ≈ $-204.69K	-0.006x	+93.04%
2016-12-31	₩27.68 Billion ≈ $18.76 Million	₩-2.27 Billion ≈ $-1.54 Million	-0.082x	+51.02%
2015-12-31	₩25.90 Billion ≈ $17.55 Million	₩-4.34 Billion ≈ $-2.94 Million	-0.168x	-121.60%
2014-12-31	₩13.44 Billion ≈ $9.11 Million	₩10.43 Billion ≈ $7.07 Million	0.776x	+190.44%
2013-12-31	₩11.03 Billion ≈ $7.48 Million	₩2.95 Billion ≈ $2.00 Million	0.267x	-86.53%
2012-12-31	₩7.04 Billion ≈ $4.77 Million	₩13.97 Billion ≈ $9.47 Million	1.984x	--

About HLB Life Science Co. Ltd

KQ:067630 Korea Pharmaceuticals

Market Cap

$106.34 Million

₩156.92 Billion KRW

Market Cap Rank

#18757 Global

#876 in Korea

Share Price

₩3350.00

Change (1 day)

-4.96%

52-Week Range

₩1640.00 - ₩4660.00

All Time High

₩23674.87